Snatch Shares of LXRX 10.6% Cheaper Than the CEO Did
February 25, 2020 at 10:36 AM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 18, Lexicon Pharmaceuticals, Inc.'s CEO, Lonnel Coats, invested $155,000.00 into 50,000 shares of LXRX, for a cost per share of $3.10..
